We are continuing to see a range of terminologies used to describe products related to the cannabis plant, including cannabinoids, whole flower medicinal cannabis, cannabis, medicinal marijuana, marijuana and hemp. Althugh these terms are often used interchangably, they do have differences.
For us, it is very important that we use consistent and present terminology when using these terms. We would like to make clear the distinction between them.
What do they mean?
Medicinal – the “medicinal” prefix is attributed to these terms to indicate the purpose of use, for example “medicinal cannabis” or “medicinal marijuana”. This is used to indicate they are being used for medicinal reasons, in the treatment of an indication, such as chronic pain, anxiety or insomnia and other conditions related to CEDS, rather than a recreational use.
Marijuana – marijuana refers to cannabis plants high in THC (illicit cannabis). The word marijuana is believed to have originated from Mexico. In the US medical marijuana is not regulated as it is here in Australia. In the US patients decide what medical marijuana products they want to use, and they are generally smoked or consumed as edibles.
Cannabis– cannabis and refer to all products from the Cannabis Sativa plant, and medical use is related to the use of “whole flower” or in Europe “cannabis inflorescence”.
Whole Flower – whole flower is raw plant material derived from the cannabis plant, usually for medicinal purposes. These products can be smoked or vaped. This is a common option in the Australian market but but it does not provide the dosing required for medical regimes. We do not provide whole flower products at the clinic for a range of good reasons, learn more in our article – Why Not Offer Whole Flower?
Cannabinoids – are the molecules found in the cannabis plant that provide medical outcomes. The main ones you may have heard of CBD (cannabidiol) and THC (∆9- tetrahydrocannabinol) are usually what is prescribed by healthcare professionals. Over 100 cannabinoids have been identified. While Cannabis as a plant will never be approved, cannabinoids have already been approved in the form of Epidyolex (CBD 100mg/ml) for paediatric seizure disorders and Sativex (CBD:THC 1:1) for MS (multiple sclerosis).
So, which does eCS Clinic provide access to?
The medications provided by eCS Clinic where appropriate are cannabinoid medications. We prescribe compounds derived from cannabis which can be accuratley and reliabily dosed and titrated to ensure a consistent outcome for patients. Medicinal cannabinoids are available in a range of forms, including oil, lozenges, capsules, cream, supositories, and pessaries. The form of cannabinoid medication is decided by your eCS Specialist to optimise patient results.